ABX-EGF

DRUG5 trials

Sponsors

Amgen, Abgenix

Conditions

CarcinomaColorectal CancerLung CancerNeoplasm MetastasisNon-Small Cell Lung CancerNon-small Cell Lung CancerProstate Cancer

Phase 2

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

CompletedNCT00034346

AmgenLung Cancer, Neoplasm Metastasis, Non-Small Cell Lung Cancer

Start: 2002-01-31Target: 194Updated: 2007-12-24

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

CompletedNCT00061126

AbgenixProstate Cancer

Start: 2003-04-30Target: 50Updated: 2005-06-24

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

CompletedNCT00101920

AmgenLung Cancer, Neoplasm Metastasis, Non-small Cell Lung Cancer

Start: 2003-06-30End: 2004-12-31Updated: 2010-10-15

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

CompletedNCT00111774

AmgenCarcinoma, Colorectal Cancer

Start: 2002-03-31Target: 150Updated: 2013-05-14

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

CompletedNCT00113776

AmgenColorectal Cancer

Updated: 2011-01-21